top of page

A NEW MODEL FOR COLLABORATIVE CLINICAL RESEARCH
IN ONCOLOGY

WE ARE AN INTERNATIONAL, INNOVATIVE, RESEARCH ORGANIZATION IN CLINICAL ONCOLOGY. OUR GOAL IS TO GENERATE THE MOST INNOVATIVE CLINICAL TRIALS WITH THE MOST PROMISING DRUGS BY FOSTERING GLOBAL COLLABORATIONS BETWEEN EXPERT CLINICAL INVESTIGATORS/KOLs AND PHARMACEUTICAL COMPANIES/BIOTECHS. 

WE CONNECT THE BEST TREATMENTS WITH THE BRIGHTEST MINDS

home_fondo_link_barra.jpg

MEDSIR is a company founded by scientific experts in 2012. We are dedicated to the design and management of strategic clinical trials in oncology, from study conception to the publication of study results.

 

MEDSIR favors a new model for collaborative clinical research in oncology development that aims to combine the highest scientific value with the strategic development of novel cancer treatments, with the final goal of benefiting cancer patients worldwide. Our goal is to generate win-win scenarios for all stakeholders involved in independent clinical research.


 
TOGETHER WE CAN BUILD A BRIGHTER FUTURE

THINK TANK MEETING 2022

home_fondo_link_barra.jpg

We had the pleasure to host a Think Tank Meeting in Barcelona: 5 Key Opinion Leaders (KOLs) in breast cancer field and over 25 breast cancer oncologists from emerging markets of LATAM, Asia and AfME, were invited to a 3-day-dynamic, with the aim of establishing new connections with their colleagues worldwide while learning how to design innovative and strategic trials.


If you’re interested in taking part of the next Think Tank Meeting or would like to sponsor it, don’t hesitate to contact us! 

WHAT WE DO

home_fondo_link_barra.jpg

Our international team of high-level clinicians and research experts are passionate about collaborating with medical oncologists and pharmaceutical companies to develop the best treatments for patients as quickly as possible.

MEDSIR IN NUMBERS

home_fondo_link_barra.jpg

>31
INDUSTRY FUNDERS

>232  
SITES

>48
TRIALS DEVELOPED

>432  
RESEARCH
COLLABORATORS

>400 
IDEAS
GENERATED

>88  
STAFF
DEDICATED

>2310 
PATIENTS
RECRUITED

OUR STUDIES

home_fondo_link_barra.jpg

Some examples of MEDSIR ideas matured into strategic clinical trials.

3d-rendering-luxury-new-background-white-honeycomb-hexagon-pattern-honeycomb-3d-illustrati

PHERGAIN

BREAST

Chemotherapy-free trastuzumab and pertuzumab in HER2-positive breast cancer: A FDG-PET response-adapted strategy

3d-rendering-luxury-new-background-white-honeycomb-hexagon-pattern-honeycomb-3d-illustrati

SLLIP

LUNG

Spanish Lung Liquid vs. Invasive biopsy Program (SLLIP)

3d-rendering-luxury-new-background-white-honeycomb-hexagon-pattern-honeycomb-3d-illustrati

ORPHEUS

PENIS

Phase II Study of the Efficacy of INCMGA00012 in Penile Squamous Cell Carcinoma

3d-rendering-luxury-new-background-white-honeycomb-hexagon-pattern-honeycomb-3d-illustrati

PARSIFAL

BREAST

Palbociclib with fulvestrant or letrozole for HER-, ER+ metastatic breast cancer

close-up-view-young-female-doctor-writing-medical-charts-with-tablet-office-room.jpg

For any question or suggestion,
we are here for you.

bottom of page